Ads
related to: Acute Myeloid Leukemia- Safety Profile
Physicians, See Important Safety
Information About This Treatment.
- Treatment Option
Visit The Physician Website To
Learn More About This Treatment.
- View Patient Profiles
Patients Experience Treatment
Intolerance & Suboptimal Responses
- Efficacy Information
Physicians, See How This Treatment
May Help Your Patients Today.
- $0 Co-Pay Information
Patients With Private Insurance
Could Save On Their Prescription.
- Mechanism Of Action
Learn How To Treat Patients
With Ph+ CML-CP Today.
- Safety Profile
Search results
New way found to treat early relapse in leukemia
Medical Xpress· 13 hours agoThe research, published in the Journal of Clinical Oncology, has shown how a new combination of a molecular technology called measurable residual disease...
Targeting RAS proteins may prevent relapse in acute myeloid leukemia
Medical Xpress· 7 days agoThe team found that the resistant cancer had up-regulated multiple other signaling pathways to...
Exploring the role of MIA-602 in overcoming doxorubicin-resistance in acute myeloid leukemia
Medical Xpress· 5 days agoA new research paper titled "Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia" has been published in Oncotarget.
Exploring the role of RNA modification in normal hematopoiesis and acute myeloid leukemia...
Medical Xpress· 5 days agoGenetic dysregulation of gene expression in hematopoietic stem cells (HSCs) hinders their normal differentiation into myeloid cells, resulting in the accumulation of immature blast cells and ...
Syros (SYRS) Up on FDA Fast Track Tag for Tamibarotene in AML
Zacks via Yahoo Finance· 6 days agoThe FDA bestows a Fast Track Designation to Syros' (SYRS) pipeline candidate, tamibarotene, in...
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
InvestorPlace· 13 hours agoThe broader medical therapeutic sector is already volatile so it stands to reason in some sense to...
Mylota dosage: Form, strengths, how to use, and more
Medical News Today· 7 days agoMylotarg (gemtuzumab ozogamicin) is a brand-name drug that’s prescribed to treat certain types of acute myeloid leukemia in adults and ...
Blasting cancer with 120 drugs? Why FIU and a Miami children’s hospital tried it
Miami Herald via AOL· 5 days agoEight-year-old Logan Jenner might not be here right now if it weren’t for his little sister Mary....
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for...
Investing.com· 6 days agoPresenting a summary of the Phase...
Kyle Michael Wool Acquires 19,000 Shares of Dominari Holdings Inc. (NASDAQ:DOMH) Stock
ETF DAILY NEWS· 6 days agoDominari Holdings Inc. (NASDAQ:DOMH – Get Free Report) President Kyle Michael Wool purchased 19,000 shares of the business’s stock in a transaction on Thursday, April 4th. The shares were bought ...
Ads
related to: Acute Myeloid Leukemia
